BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31971830)

  • 1. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
    Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P
    Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increased level of MiR-222-3p is associated with TMP2 suppression, ERK activation and is associated with metastasis and a poor prognosis in renal clear cell carcinoma.
    Lyu J; Zhu Y; Zhang Q
    Cancer Biomark; 2020; 28(2):141-149. PubMed ID: 32116235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma.
    He X; Liao S; Lu D; Zhang F; Sun Y; Wu Y
    Int J Med Sci; 2021; 18(1):150-156. PubMed ID: 33390783
    [No Abstract]   [Full Text] [Related]  

  • 6. Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression.
    Li W; Yang D; Zhang Y; Zhao S; Li D; Liu M
    Oncol Rep; 2020 Nov; 44(5):1985-1996. PubMed ID: 33000253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression.
    Zhang S; Hong Z; Li Q; Lei J; Huang H; Liu Q
    Biomed Pharmacother; 2016 May; 80():213-219. PubMed ID: 27133059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z; Ma Z; Xu X
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
    Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W
    Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma.
    Jiao D; Wu M; Ji L; Liu F; Liu Y
    Oncol Res; 2018 Mar; 26(2):249-259. PubMed ID: 28550686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-590-5p regulates cell viability, apoptosis, migration and invasion of renal cell carcinoma cell lines through targeting ARHGAP24.
    Wang L; Wei WQ; Wu ZY; Wang GC
    Mol Biosyst; 2017 Nov; 13(12):2564-2573. PubMed ID: 29019371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
    Wang X; Li H; Cui L; Feng J; Fan Q
    Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
    Lin L; Cai J
    J Cell Biochem; 2020 Nov; 121(11):4377-4385. PubMed ID: 31904147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-376a functions as tumor suppressor by targeting SGK3 in renal cell carcinoma.
    Fan XR; Zhang ZY; Wang RH; Li Y; Mao QZ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3726-3732. PubMed ID: 31114998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudogene HSPB1P1 contributes to renal cell carcinoma proliferation and metastasis by targeting miR-296-5p to regulate HMGA1 expression.
    Chen Z; Wang Z; Chen Z; Fu F; Huang X; Huang Z
    Cell Biol Int; 2021 Dec; 45(12):2479-2489. PubMed ID: 34431162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.
    Zhu S; Huang Y; Su X
    Med Sci Monit; 2016 Jan; 22():183-90. PubMed ID: 26779781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0008717 promotes renal cell carcinoma progression by upregulating FBXO17 via targeting miR-217.
    Shen S; Jiang M; Deng W; Liu X; Xiong J; Zeng Z; Zhao H; Zeng X; Fu B
    J Gene Med; 2022 Nov; 24(11):e3418. PubMed ID: 35357059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.